1.0Biociências Vigilanteshttps://vigilantbiosciences.com/ptWendy Vrijenhoekhttps://vigilantbiosciences.com/pt/author/wendy-vrijenhoek/rich600338<blockquote class="wp-embedded-content" data-secret="ljcLxYB5Ql"><a href="https://vigilantbiosciences.com/pt/dipl-team-member/dex-manley/">Dex Manley</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://vigilantbiosciences.com/pt/dipl-team-member/dex-manley/embed/#?secret=ljcLxYB5Ql" width="600" height="338" title="“Dex Manley” — Vigilant Biosciences®" data-secret="ljcLxYB5Ql" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://vigilantbiosciences.com/wp-includes/js/wp-embed.min.js </script>https://vigilantbiosciences.com/wp-content/uploads/Dex_720x720-1.jpg720720Dex joined Vigilant Biosciences® in January 2020 as Director of IT & Program Management and was promoted to Senior Director of Software Systems in April 2023. Dex brings over 15 years of experience across medical devices, enterprise SaaS, and consumer technology, owning Vigilant’s software roadmap and cybersecurity program. Previously, he managed cancer ablation technology programs […]